However, recent available evidence indicates that multiple low-dose treatment can be effective: in EGFR-mutant lung cancer, vertical targeting of EGFR signaling pathway with three or four drugs can be effective even when the drugs are used at 20% of the single agent concentration (188). This evidence concerns the gene EGFR and lung cancer.